Merck to acquire Burlington-based Natrix Separations

Mark Henderson
August 30, 2017

Merck, Darmstadt Germany, is acquiring Natrix Separations Inc, Burlington ON, a provider of hydrogel membrane products used to eliminate impurities during bioprocessing and accelerate the production of monoclonal antibodies and vaccines. Natrix markets both an anion exchange membrane and cation exchange membrane and is developing additional products to enable a fully single-use, full-scale biological purification process — an area of increasing importance to Merck customers. It’s estimated that the market for next-generation processing will triple between 2020 and 2025, increasing plant productivity, facility flexibility, cost efficiencies and reduced risk. Natrix is a privately held company founded in 2005. It has a large portfolio of intellectual property and is expanding rapidly into several vertical sectors including pharma, biopharma, animal health, nutraceutical and other industrial purification markets

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies.
We use cookies to provide you with a great experience and to help our website run effectively
in accordance with our Privacy Policy and Terms of Service.